RQ bio.png

RQ Biotechnology Limited

Industrial Biotech

Membership category
Corporate

Scale Space, 58 Wood Lane, London, W12 7RZ, United Kingdom

RQ Biotechnology Limited at a glance

RQ Bio’s mission is to develop potent broad-spectrum antiviral mAbs to provide instant and long-lasting immunity for vulnerable people.

About RQ Biotechnology Limited

RQ Bio’s mission has been to develop medicines based on potent broad-spectrum mAbs to provide instant and long-lasting immunity for vulnerable people at risk of severe disease or death from current and future variants of viral infections. RQ Bio has achieved this by combining innovative excellence in core areas to create a smarter approach to antibody generation. RQ Bio has multiple sources of leads and a deep collaboration with the University of Oxford. RQ Bio was founded by scientific experts previously involved with the UK BIA Antibody Taskforce, which worked to build a community of infectious disease antibody experts focused on the development of rapid and efficient delivery of highly potent neutralising antibodies to help support the UK COVID-19 response.

Therapeutic area(s)

Articles RQ Biotechnology Limited has contributed to